Scholars Central

Conference abstractPublished 26 Oct 2017

Rifampicin, Ofloxacin, Minocycline regiment in borderline lepromatous leprosy with erythema nodosum leprosum: A case report

Authors: Dyah Pratiwi Purnaningsih

Hasanuddin University, Indonesia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Leprosy is a chronic granulomatous infection caused by Mycobacterium leprae. Erythema nodosum leprosum (ENL) is an immune-mediated complication of leprosy. So far, however, there is no consensus of the most suitable new anti-microbial combination regiment. Rifampicin, Ofloxacin, Minocycline (ROM) is an alternative regimen for leprosy with high compliance. In the late 1990âÂ?Â?s, there were some studies using ROM therapy, some studies include multiple lesion of paucibacillary and multibacillary leprosy. To date there is only two reported studies that using multiple doses of ROM monthly for 24 months in Lepromatous Leprosy (LL) and Borderline Lepromatous (BL). Depending on the severity of ENL, various treatments such as non-steroid anti-inflammation in mild case and corticosteroid and thalidomide in severe cases were used. We reported a 54 years old man with red plaques and nodules on the body since three months with anesthetized. Acid-fast bacilli (AFB) staining showed positive result and Fite-Faraco examination showed a group bacilli of Mycobacterium leprae. The conclusion of anatomy, pathologic examination was borderline lepromatous leprosy with ENL. Patient was treated with Rifampicin (600 mg), Ofloxacin (400 mg), Minosiklin (100 mg) every three times a week with total of 65 doses and Prednisone 30 mg a day. After 12 months, we evaluated the patient with acid-fast bacilli stain procedure and the result was negative. Red plaque and nodules was disappeared and changed to hyperpigmentation post inflammation.

Subjects

Dermatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Dermatology and Dermatologic Diseases.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Dermatology and Dermatologic Diseases
  • SubjectDermatology
  • BylineArticles whose byline prints “Dyah Pratiwi Purnaningsih”